Mai Abdelfattah Fayez Megahed

Thrombopoietin in HCV liver disease and its role in HCV related thrombocytopenia / العلاقة بين نقص الصفائح الدموية المصاحب للاصابة بفيروس سي الكبدى المزمن و نقص هرمون الثرومبوبيوتين Mai Abdelfattah Fayez Megahed ; Supervised Hala Mahmoud Abdelhamid , Noha Mohammed Elhusseiny - Cairo : Mai Abdelfattah Fayez Megahed , 2012 - 130 Leaves : facsimiles ; 25cm

Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Internal Medicine

Egypt has the largest epidemic of hepatitis C virus (HCV) in the world. Patients with chronic hepatitis C virus (HCV) infection are at risk of a great number of extrahepatic manifestations (EHMs), up to 40-76% of patients infected with HCV develop at least one EHM during the course of the disease. Thrombopoietin is a common finding in subjects with chronic hepatitis



Hepatitis C virus Thrombocytopenia Thrombopoietin